(Q24314749)

1

0 references

Aravind Ramakrishnan

2

0 references

Kyoung-Eun Kim

3

0 references

Arnold B Rabson

Biochemical and Biophysical Research Communications

4

0 references

language of work or name

English

0 references

publication date

30 September 2005

0 references

published in

0 references

volume

335

0 references

issue

3

0 references

page(s)

865-73

0 references

cites work

The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukemia derived cell line, HSB-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

A kinase-independent function of Lck in potentiating antigen-specific T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Bcl-3-mediated nuclear regulation of the NF-kappa B trans-activating factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Immunological adjuvants promote activated T cell survival via induction of Bcl-3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Immunohistochemical detection of BCL-3 in lymphoid neoplasms: a survey of 353 cases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

NF- kappa B2/p100 induces Bcl-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Negative regulation of Lck by Cbl ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Thymic tumorigenesis induced by overexpression of p56lck

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The conserved lysine of the catalytic domain of protein kinases is actively involved in the phosphotransfer reaction and not required for anchoring ATP

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Diverse effects of BCL3 phosphorylation on its modulation of NF-kappaB p52 homodimer binding to DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Bcl3, an IkappaB protein, stimulates activating protein-1 transactivation and cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

NF-kappa B-inducible BCL-3 expression is an autoregulatory loop controlling nuclear p50/NF-kappa B1 residence

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Delayed thymocyte development induced by augmented expression of p56lck

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Immunological defects in mice with a targeted disruption in Bcl-3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Two lck transcripts containing different 5' untranslated regions are present in T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

NF-κB RegulatesBCL3Transcription in T Lymphocytes Through an Intronic Enhancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021

Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.07.162

7 January 2021